Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson's disease.

Milanese C, Cerri S, Ulusoy A, Gornati SV, Plat A, Gabriels S, Blandini F, Di Monte DA, Hoeijmakers JH, Mastroberardino PG.

Cell Death Dis. 2018 Jul 26;9(8):818. doi: 10.1038/s41419-018-0848-7.

2.

Decreased mitochondrial respiration in aneurysmal aortas of Fibulin-4 mutant mice is linked to PGC1A regulation.

van der Pluijm I, Burger J, van Heijningen PM, IJpma A, van Vliet N, Milanese C, Schoonderwoerd K, Sluiter W, Ringuette LJ, Dekkers DHW, Que I, Kaijzel EL, Te Riet L, MacFarlane E, Das D, van der Linden R, Vermeij M, Demmers JA, Mastroberardino PG, Davis EC, Yanagisawa H, Dietz H, Kanaar R, Essers J.

Cardiovasc Res. 2018 Jun 21. doi: 10.1093/cvr/cvy150. [Epub ahead of print]

PMID:
29931197
3.

Mitochondrial Complex I Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease.

Milanese C, Tapias V, Gabriels S, Cerri S, Levandis G, Blandini F, Tresini M, Shiva S, Greenamyre JT, Gladwin MT, Mastroberardino PG.

Antioxid Redox Signal. 2018 Jan 1;28(1):44-61. doi: 10.1089/ars.2017.6992. Epub 2017 Sep 21.

PMID:
28816057
4.

Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia.

Zambetti NA, Ping Z, Chen S, Kenswil KJG, Mylona MA, Sanders MA, Hoogenboezem RM, Bindels EMJ, Adisty MN, Van Strien PMH, van der Leije CS, Westers TM, Cremers EMP, Milanese C, Mastroberardino PG, van Leeuwen JPTM, van der Eerden BCJ, Touw IP, Kuijpers TW, Kanaar R, van de Loosdrecht AA, Vogl T, Raaijmakers MHGP.

Cell Stem Cell. 2016 Nov 3;19(5):613-627. doi: 10.1016/j.stem.2016.08.021. Epub 2016 Sep 22.

5.

Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson's Disease.

Sepe S, Milanese C, Gabriels S, Derks KW, Payan-Gomez C, van IJcken WF, Rijksen YM, Nigg AL, Moreno S, Cerri S, Blandini F, Hoeijmakers JH, Mastroberardino PG.

Cell Rep. 2016 May 31;15(9):1866-75. doi: 10.1016/j.celrep.2016.04.071. Epub 2016 May 19.

6.

Brain Radiation Information Data Exchange (BRIDE): integration of experimental data from low-dose ionising radiation research for pathway discovery.

Karapiperis C, Kempf SJ, Quintens R, Azimzadeh O, Vidal VL, Pazzaglia S, Bazyka D, Mastroberardino PG, Scouras ZG, Tapio S, Benotmane MA, Ouzounis CA.

BMC Bioinformatics. 2016 May 11;17(1):212. doi: 10.1186/s12859-016-1068-8.

7.

Editorial: Neuronal Self-Defense: Compensatory Mechanisms in Neurodegenerative Disorders.

Parlato R, Mastroberardino PG.

Front Cell Neurosci. 2016 Jan 5;9:499. doi: 10.3389/fncel.2015.00499. eCollection 2015. No abstract available.

8.

Metals and neurodegeneration.

Aizenman E, Mastroberardino PG.

Neurobiol Dis. 2015 Sep;81:1-3. doi: 10.1016/j.nbd.2015.08.012. No abstract available.

9.

Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function.

Birket MJ, Ribeiro MC, Kosmidis G, Ward D, Leitoguinho AR, van de Pol V, Dambrot C, Devalla HD, Davis RP, Mastroberardino PG, Atsma DE, Passier R, Mummery CL.

Cell Rep. 2015 Oct 27;13(4):733-745. doi: 10.1016/j.celrep.2015.09.025. Epub 2015 Oct 17.

10.

Fibroblasts from skin biopsies as a tool for biomarker discovery in Parkinson׳s disease.

Mastroberardino PG, Ambrosi G, Blandini F, Milanese C, Sepe S.

Free Radic Biol Med. 2014 Oct;75 Suppl 1:S10. doi: 10.1016/j.freeradbiomed.2014.10.854. Epub 2014 Dec 10.

PMID:
26461279
11.

Neonatal Irradiation Leads to Persistent Proteome Alterations Involved in Synaptic Plasticity in the Mouse Hippocampus and Cortex.

Kempf SJ, Sepe S, von Toerne C, Janik D, Neff F, Hauck SM, Atkinson MJ, Mastroberardino PG, Tapio S.

J Proteome Res. 2015 Nov 6;14(11):4674-86. doi: 10.1021/acs.jproteome.5b00564. Epub 2015 Oct 12.

12.

Impaired enzymatic defensive activity, mitochondrial dysfunction and proteasome activation are involved in RTT cell oxidative damage.

Cervellati C, Sticozzi C, Romani A, Belmonte G, De Rasmo D, Signorile A, Cervellati F, Milanese C, Mastroberardino PG, Pecorelli A, Savelli V, Forman HJ, Hayek J, Valacchi G.

Biochim Biophys Acta. 2015 Oct;1852(10 Pt A):2066-74. doi: 10.1016/j.bbadis.2015.07.014. Epub 2015 Jul 17.

13.

Women have more potential to induce browning of perirenal adipose tissue than men.

van den Beukel JC, Grefhorst A, Hoogduijn MJ, Steenbergen J, Mastroberardino PG, Dor FJ, Themmen AP.

Obesity (Silver Spring). 2015 Aug;23(8):1671-9. doi: 10.1002/oby.21166. Epub 2015 Jul 14.

14.

Low-dose ionizing radiation rapidly affects mitochondrial and synaptic signaling pathways in murine hippocampus and cortex.

Kempf SJ, Moertl S, Sepe S, von Toerne C, Hauck SM, Atkinson MJ, Mastroberardino PG, Tapio S.

J Proteome Res. 2015 May 1;14(5):2055-64. doi: 10.1021/acs.jproteome.5b00114. Epub 2015 Apr 6.

PMID:
25807253
15.

Type 2 Transglutaminase, mitochondria and Huntington's disease: menage a trois.

Altuntas S, D'Eletto M, Rossin F, Hidalgo LD, Farrace MG, Falasca L, Piredda L, Cocco S, Mastroberardino PG, Piacentini M, Campanella M.

Mitochondrion. 2014 Nov;19 Pt A:97-104. doi: 10.1016/j.mito.2014.09.008. Epub 2014 Sep 28. Review.

PMID:
25262960
16.

Direct activating effects of adrenocorticotropic hormone (ACTH) on brown adipose tissue are attenuated by corticosterone.

van den Beukel JC, Grefhorst A, Quarta C, Steenbergen J, Mastroberardino PG, Lombès M, Delhanty PJ, Mazza R, Pagotto U, van der Lely AJ, Themmen AP.

FASEB J. 2014 Nov;28(11):4857-67. doi: 10.1096/fj.14-254839. Epub 2014 Aug 1.

PMID:
25085924
17.

Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis.

Rossin F, D'Eletto M, Falasca L, Sepe S, Cocco S, Fimia GM, Campanella M, Mastroberardino PG, Farrace MG, Piacentini M.

Cell Death Differ. 2015 Mar;22(3):408-18. doi: 10.1038/cdd.2014.106. Epub 2014 Jul 25.

18.

Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease.

Sanders LH, McCoy J, Hu X, Mastroberardino PG, Dickinson BC, Chang CJ, Chu CT, Van Houten B, Greenamyre JT.

Neurobiol Dis. 2014 Oct;70:214-23. doi: 10.1016/j.nbd.2014.06.014. Epub 2014 Jun 27.

19.

Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease.

Ambrosi G, Ghezzi C, Sepe S, Milanese C, Payan-Gomez C, Bombardieri CR, Armentero MT, Zangaglia R, Pacchetti C, Mastroberardino PG, Blandini F.

Biochim Biophys Acta. 2014 Sep;1842(9):1385-94. doi: 10.1016/j.bbadis.2014.05.008. Epub 2014 May 20.

20.

PGC-1α and reactive oxygen species regulate human embryonic stem cell-derived cardiomyocyte function.

Birket MJ, Casini S, Kosmidis G, Elliott DA, Gerencser AA, Baartscheer A, Schumacher C, Mastroberardino PG, Elefanty AG, Stanley EG, Mummery CL.

Stem Cell Reports. 2013 Dec 12;1(6):560-74. doi: 10.1016/j.stemcr.2013.11.008. eCollection 2013.

21.

Defects in mitochondrial clearance predispose human monocytes to interleukin-1β hypersecretion.

van der Burgh R, Nijhuis L, Pervolaraki K, Compeer EB, Jongeneel LH, van Gijn M, Coffer PJ, Murphy MP, Mastroberardino PG, Frenkel J, Boes M.

J Biol Chem. 2014 Feb 21;289(8):5000-12. doi: 10.1074/jbc.M113.536920. Epub 2013 Dec 19.

22.

BACH2: a marker of DNA damage and ageing.

Uittenboogaard LM, Payan-Gomez C, Pothof J, van Ijcken W, Mastroberardino PG, van der Pluijm I, Hoeijmakers JH, Tresini M.

DNA Repair (Amst). 2013 Nov;12(11):982-92. doi: 10.1016/j.dnarep.2013.08.016. Epub 2013 Sep 24.

23.

Expression of Ambra1 in mouse brain during physiological and Alzheimer type aging.

Sepe S, Nardacci R, Fanelli F, Rosso P, Bernardi C, Cecconi F, Mastroberardino PG, Piacentini M, Moreno S.

Neurobiol Aging. 2014 Jan;35(1):96-108. doi: 10.1016/j.neurobiolaging.2013.07.001. Epub 2013 Aug 2.

PMID:
23910655
24.

Nucleotide excision repair in chronic neurodegenerative diseases.

Sepe S, Payan-Gomez C, Milanese C, Hoeijmakers JH, Mastroberardino PG.

DNA Repair (Amst). 2013 Aug;12(8):568-77. doi: 10.1016/j.dnarep.2013.04.009. Epub 2013 May 28. Review.

PMID:
23726220
25.

Redox status and bioenergetics liaison in cancer and neurodegeneration.

Filomeni G, Bolaños JP, Mastroberardino PG.

Int J Cell Biol. 2012;2012:659645. Epub 2012 Sep 11. No abstract available.

26.

Thiol oxidation and altered NR2B/NMDA receptor functions in in vitro and in vivo pilocarpine models: implications for epileptogenesis.

Di Maio R, Mastroberardino PG, Hu X, Montero LM, Greenamyre JT.

Neurobiol Dis. 2013 Jan;49:87-98. doi: 10.1016/j.nbd.2012.07.013. Epub 2012 Jul 21.

PMID:
22824136
27.

Pilocapine alters NMDA receptor expression and function in hippocampal neurons: NADPH oxidase and ERK1/2 mechanisms.

Di Maio R, Mastroberardino PG, Hu X, Montero L, Greenamyre JT.

Neurobiol Dis. 2011 Jun;42(3):482-95. doi: 10.1016/j.nbd.2011.02.012. Epub 2011 Mar 17.

PMID:
21397025
28.

Single-cell redox imaging demonstrates a distinctive response of dopaminergic neurons to oxidative insults.

Horowitz MP, Milanese C, Di Maio R, Hu X, Montero LM, Sanders LH, Tapias V, Sepe S, van Cappellen WA, Burton EA, Greenamyre JT, Mastroberardino PG.

Antioxid Redox Signal. 2011 Aug 15;15(4):855-71. doi: 10.1089/ars.2010.3629. Epub 2011 Jun 6.

29.

Embryonic mouse blood flow and oxygen correlate with early pancreatic differentiation.

Shah SR, Esni F, Jakub A, Paredes J, Lath N, Malek M, Potoka DA, Prasadan K, Mastroberardino PG, Shiota C, Guo P, Miller KA, Hackam DJ, Burns RC, Tulachan SS, Gittes GK.

Dev Biol. 2011 Jan 15;349(2):342-9. doi: 10.1016/j.ydbio.2010.10.033. Epub 2010 Nov 2.

30.

Type 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential.

Mastroberardino PG, Piacentini M.

J Intern Med. 2010 Nov;268(5):419-31. doi: 10.1111/j.1365-2796.2010.02275.x. Review.

31.

Lessons from the rotenone model of Parkinson's disease.

Greenamyre JT, Cannon JR, Drolet R, Mastroberardino PG.

Trends Pharmacol Sci. 2010 Apr;31(4):141-2; author reply 142-3. doi: 10.1016/j.tips.2009.12.006. Epub 2010 Jan 22. Review. No abstract available.

32.

Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson disease.

Bayir H, Kapralov AA, Jiang J, Huang Z, Tyurina YY, Tyurin VA, Zhao Q, Belikova NA, Vlasova II, Maeda A, Zhu J, Na HM, Mastroberardino PG, Sparvero LJ, Amoscato AA, Chu CT, Greenamyre JT, Kagan VE.

J Biol Chem. 2009 Jun 5;284(23):15951-69. doi: 10.1074/jbc.M900418200. Epub 2009 Apr 7.

33.

A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease.

Mastroberardino PG, Hoffman EK, Horowitz MP, Betarbet R, Taylor G, Cheng D, Na HM, Gutekunst CA, Gearing M, Trojanowski JQ, Anderson M, Chu CT, Peng J, Greenamyre JT.

Neurobiol Dis. 2009 Jun;34(3):417-31. doi: 10.1016/j.nbd.2009.02.009. Epub 2009 Feb 26.

34.

More than two sides of a coin? How to detect the multiple activities of type 2 transglutaminase.

Rodolfo C, Falasca L, Di Giacomo G, Mastroberardino PG, Piacentini M.

Methods Enzymol. 2008;442:201-12. doi: 10.1016/S0076-6879(08)01410-9.

PMID:
18662571
35.

A FRET-based method to study protein thiol oxidation in histological preparations.

Mastroberardino PG, Orr AL, Hu X, Na HM, Greenamyre JT.

Free Radic Biol Med. 2008 Oct 1;45(7):971-81. doi: 10.1016/j.freeradbiomed.2008.06.018. Epub 2008 Jun 27.

36.

N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.

Orr AL, Li S, Wang CE, Li H, Wang J, Rong J, Xu X, Mastroberardino PG, Greenamyre JT, Li XJ.

J Neurosci. 2008 Mar 12;28(11):2783-92. doi: 10.1523/JNEUROSCI.0106-08.2008.

37.

Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders.

Battaglia G, Farrace MG, Mastroberardino PG, Viti I, Fimia GM, Van Beeumen J, Devreese B, Melino G, Molinaro G, Busceti CL, Biagioni F, Nicoletti F, Piacentini M.

J Neurochem. 2007 Jan;100(1):36-49. Epub 2006 Oct 25.

38.

"Tissue" transglutaminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes.

Mastroberardino PG, Farrace MG, Viti I, Pavone F, Fimia GM, Melino G, Rodolfo C, Piacentini M.

Biochim Biophys Acta. 2006 Sep-Oct;1757(9-10):1357-65. Epub 2006 Aug 3.

39.

Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis.

Szondy Z, Mastroberardino PG, Váradi J, Farrace MG, Nagy N, Bak I, Viti I, Wieckowski MR, Melino G, Rizzuto R, Tósaki A, Fesus L, Piacentini M.

Cell Death Differ. 2006 Oct;13(10):1827-9. Epub 2006 Mar 10. No abstract available.

40.

Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.

Betarbet R, Canet-Aviles RM, Sherer TB, Mastroberardino PG, McLendon C, Kim JH, Lund S, Na HM, Taylor G, Bence NF, Kopito R, Seo BB, Yagi T, Yagi A, Klinefelter G, Cookson MR, Greenamyre JT.

Neurobiol Dis. 2006 May;22(2):404-20. Epub 2006 Jan 24.

PMID:
16439141
41.

Type 2 transglutaminase and cell death.

Piacentini M, Amendola A, Ciccosanti F, Falasca L, Farrace MG, Mastroberardino PG, Nardacci R, Oliverio S, Piredda L, Rodolfo C, Autuori F.

Prog Exp Tumor Res. 2005;38:58-74. Review. No abstract available.

PMID:
15746529
42.

AIF deficiency compromises oxidative phosphorylation.

Vahsen N, Candé C, Brière JJ, Bénit P, Joza N, Larochette N, Mastroberardino PG, Pequignot MO, Casares N, Lazar V, Feraud O, Debili N, Wissing S, Engelhardt S, Madeo F, Piacentini M, Penninger JM, Schägger H, Rustin P, Kroemer G.

EMBO J. 2004 Nov 24;23(23):4679-89. Epub 2004 Nov 4.

43.

Does prothymosin-alpha act as molecular switch between apoptosis and autophagy?

Piacentini M, Evangelisti C, Mastroberardino PG, Nardacci R, Kroemer G.

Cell Death Differ. 2003 Sep;10(9):937-9. No abstract available.

44.

Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells.

Szondy Z, Sarang Z, Molnar P, Nemeth T, Piacentini M, Mastroberardino PG, Falasca L, Aeschlimann D, Kovacs J, Kiss I, Szegezdi E, Lakos G, Rajnavolgyi E, Birckbichler PJ, Melino G, Fesus L.

Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7812-7. Epub 2003 Jun 16.

45.

'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease.

Mastroberardino PG, Iannicola C, Nardacci R, Bernassola F, De Laurenzi V, Melino G, Moreno S, Pavone F, Oliverio S, Fesus L, Piacentini M.

Cell Death Differ. 2002 Sep;9(9):873-80.

Supplemental Content

Loading ...
Support Center